BSE Announcement

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 7 August 2026.

Aarti Surfactants will hold a meeting of the Board of Directors of the Company on 1 August 2026.

Abirami Financial Services (India) announced that the 33th Annual General Meeting(AGM) of the company will be held on 18 September 2026.

ACE EduTrend announced that the 32th Annual General Meeting(AGM) of the company will be held on 25 August 2026.

Aditya Consumer Marketing will hold a meeting of the Board of Directors of the Company on 31 July 2026.

Aditya Vision will hold a meeting of the Board of Directors of the Company on 31 July 2026.

Ajmera Realty & Infra India will hold a meeting of the Board of Directors of the Company on 4 August 2026.

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Prucalopride Tablets, 1 mg and 2 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA Inc. Prucalopride tablets are serotonin-4 receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. 

Prucalopride Tablets, 1 mg and 2 mg, have an estimated market size of US$ 100 million for twelve months ending March 2026 according to IQVIA.

Amarjothi Spinning Mills announced that the Annual General Meeting(AGM) of the company will be held on 28 August 2026.

Amin Tannery will hold a meeting of the Board of Directors of the Company on 10 August 2026.